메뉴 건너뛰기




Volumn 42, Issue 2, 2013, Pages 535-542

HGF regulates VEGF expression via the c-Met receptor downstream pathways, PI3K/Akt, MAPK and STAT3, in CT26 murine cells

Author keywords

Angiogenesis; C Met; CT26; Hepatocyte growth factor; NK4; Vascular endothelial cell growth factor

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; DNA; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; STAT3 PROTEIN; VASCULOTROPIN;

EID: 84873669382     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2012.1728     Document Type: Article
Times cited : (86)

References (42)
  • 1
    • 0034648765 scopus 로고    scopus 로고
    • Angiogenesis in cancer and other diseases
    • Carmeliet P and Jain RK: Angiogenesis in cancer and other diseases. Nature 407: 249-257, 2000.
    • (2000) Nature , vol.407 , pp. 249-257
    • Carmeliet, P.1    Jain, R.K.2
  • 2
    • 0026485002 scopus 로고
    • Vascular endothelial growth factor induced by hypoxia
    • may mediate hypoxia-initiated angiogenesis
    • Shweiki D, Itin A, Soffer D and Keshet E: Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359: 843-845, 1992.
    • (1992) Nature , vol.359 , pp. 843-845
    • Shweiki, D.1    Itin, A.2    Soffer, D.3    Keshet, E.4
  • 3
    • 34547124062 scopus 로고    scopus 로고
    • Hypoxia: A key regulator of angiogenesis in cancer
    • Liao D and Johnson RS: Hypoxia: a key regulator of angiogenesis in cancer. Cancer Metastasis Rev 26: 281-290, 2007.
    • (2007) Cancer Metastasis Rev , vol.26 , pp. 281-290
    • Liao, D.1    Johnson, R.S.2
  • 4
    • 0036551486 scopus 로고    scopus 로고
    • Scatter-factor and semaphorin receptors: Cell signalling for invasive growth
    • Trusolino L and Comoglio PM: Scatter-factor and semaphorin receptors: cell signalling for invasive growth. Nat Rev Cancer 2: 289-300, 2002.
    • (2002) Nat Rev Cancer , vol.2 , pp. 289-300
    • Trusolino, L.1    Comoglio, P.M.2
  • 5
    • 0024427178 scopus 로고
    • Molecular cloning and expression of human hepatocyte growth factor
    • Nakamura T, Nishizawa T, Hagiya M, et al: Molecular cloning and expression of human hepatocyte growth factor. Nature 342: 440-443, 1989.
    • (1989) Nature , vol.342 , pp. 440-443
    • Nakamura, T.1    Nishizawa, T.2    Hagiya, M.3
  • 6
    • 0030911921 scopus 로고    scopus 로고
    • Hepatocyte growth factor/scatter factor, a cytokine playing multiple and converse roles
    • Jiang WG and Hiscox S: Hepatocyte growth factor/scatter factor, a cytokine playing multiple and converse roles. Histol Histopathol 12: 537-555, 1997.
    • (1997) Histol Histopathol , vol.12 , pp. 537-555
    • Jiang, W.G.1    Hiscox, S.2
  • 7
    • 0029985372 scopus 로고    scopus 로고
    • Emerging multipotent aspects of hepatocyte growth factor
    • Matsumoto K and Nakamura T: Emerging multipotent aspects of hepatocyte growth factor. J Biochem 119: 591-600, 1996.
    • (1996) J Biochem , vol.119 , pp. 591-600
    • Matsumoto, K.1    Nakamura, T.2
  • 8
    • 0026722243 scopus 로고
    • Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth
    • Bussolino F, Di Renzo MF, Ziche M, et al: Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol 119: 629-641, 1992.
    • (1992) J Cell Biol , vol.119 , pp. 629-641
    • Bussolino, F.1    Di Renzo, M.F.2    Ziche, M.3
  • 9
    • 0025805633 scopus 로고
    • Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product
    • Bottaro DP, Rubin JS, Faletto DL, et al: Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 251: 802-804, 1991.
    • (1991) Science , vol.251 , pp. 802-804
    • Bottaro, D.P.1    Rubin, J.S.2    Faletto, D.L.3
  • 11
    • 44449151030 scopus 로고    scopus 로고
    • Drug development of MET inhibitors: Targeting oncogene addiction and expedience
    • Comoglio PM, Giordano S and Trusolino L: Drug development of MET inhibitors: targeting oncogene addiction and expedience. Nat Rev Drug Discov 7: 504-516, 2008.
    • (2008) Nat Rev Drug Discov , vol.7 , pp. 504-516
    • Comoglio, P.M.1    Giordano, S.2    Trusolino, L.3
  • 12
    • 0036006814 scopus 로고    scopus 로고
    • Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition
    • Maulik G, Shrikhande A, Kijima T, Ma PC, Morrison PT and Salgia R: Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition. Cytokine Growth Factor Rev 13: 41-59, 2002.
    • (2002) Cytokine Growth Factor Rev , vol.13 , pp. 41-59
    • Maulik, G.1    Shrikhande, A.2    Kijima, T.3    Ma, P.C.4    Morrison, P.T.5    Salgia, R.6
  • 13
    • 0028946604 scopus 로고
    • Overexpression and amplification of the met/HGF receptor gene during the progression of colorectal cancer
    • Di Renzo MF, Olivero M, Giacomini A, et al: Overexpression and amplification of the met/HGF receptor gene during the progression of colorectal cancer. Clin Cancer Res 1: 147-154, 1995.
    • (1995) Clin Cancer Res , vol.1 , pp. 147-154
    • Di Renzo, M.F.1    Olivero, M.2    Giacomini, A.3
  • 14
    • 0032523074 scopus 로고    scopus 로고
    • Expression of c-met is a strong independent prognostic factor in breast carcinoma
    • Ghoussoub RA, Dillon DA, D'Aquila T, Rimm EB, Fearon ER and Rimm DL: Expression of c-met is a strong independent prognostic factor in breast carcinoma. Cancer 82: 1513-1520, 1998.
    • (1998) Cancer , vol.82 , pp. 1513-1520
    • Ghoussoub, R.A.1    Dillon, D.A.2    D'Aquila, T.3    Rimm, E.B.4    Fearon, E.R.5    Rimm, D.L.6
  • 15
    • 30944452172 scopus 로고    scopus 로고
    • Genomic amplification of MET with boundaries within fragile site FRA7G and upregulation of MET pathways in esophageal adenocarcinoma
    • Miller CT, Lin L, Casper AM, et al: Genomic amplification of MET with boundaries within fragile site FRA7G and upregulation of MET pathways in esophageal adenocarcinoma. Oncogene 25: 409-418, 2006.
    • (2006) Oncogene , vol.25 , pp. 409-418
    • Miller, C.T.1    Lin, L.2    Casper, A.M.3
  • 16
    • 0027219258 scopus 로고
    • A novel recognition motif for phosphatidylinositol 3-kinase binding mediates its association with the hepatocyte growth factor/scatter factor receptor
    • Ponzetto C, Bardelli A, Maina F, et al: A novel recognition motif for phosphatidylinositol 3-kinase binding mediates its association with the hepatocyte growth factor/scatter factor receptor. Mol Cell Biol 13: 4600-4608, 1993.
    • (1993) Mol Cell Biol , vol.13 , pp. 4600-4608
    • Ponzetto, C.1    Bardelli, A.2    Maina, F.3
  • 17
    • 0035793091 scopus 로고    scopus 로고
    • Anti-apoptotic signaling by hepatocyte growth factor/Met via the phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase pathways
    • Xiao GH, Jeffers M, Bellacosa A, et al: Anti-apoptotic signaling by hepatocyte growth factor/Met via the phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase pathways. Proc Natl Acad Sci USA 98: 247-252, 2001.
    • (2001) Proc Natl Acad Sci USA , vol.98 , pp. 247-252
    • Xiao, G.H.1    Jeffers, M.2    Bellacosa, A.3
  • 18
    • 0032518375 scopus 로고    scopus 로고
    • Induction of epithelial tubules by growth factor HGF depends on the STAT pathway
    • Boccaccio C, Andò M, Tamagnone L, et al: Induction of epithelial tubules by growth factor HGF depends on the STAT pathway. Nature 391: 285-288, 1998.
    • (1998) Nature , vol.391 , pp. 285-288
    • Boccaccio, C.1    Andò, M.2    Tamagnone, L.3
  • 19
    • 0242492548 scopus 로고    scopus 로고
    • Using gene expression profiling to identify the molecular basis of the synergistic actions of hepatocyte growth factor and vascular endothelial growth factor in human endothelial cells
    • Gerritsen ME, Tomlinson JE, Zlot C, Ziman M and Hwang S: Using gene expression profiling to identify the molecular basis of the synergistic actions of hepatocyte growth factor and vascular endothelial growth factor in human endothelial cells. Br J Pharmacol 140: 595-610, 2003.
    • (2003) Br J Pharmacol , vol.140 , pp. 595-610
    • Gerritsen, M.E.1    Tomlinson, J.E.2    Zlot, C.3    Ziman, M.4    Hwang, S.5
  • 20
    • 0035421326 scopus 로고    scopus 로고
    • Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma
    • Dong G, Chen Z, Li ZY, Yeh NT, Bancroft CC and Van Waes C: Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma. Cancer Res 61: 5911-5918, 2001.
    • (2001) Cancer Res , vol.61 , pp. 5911-5918
    • Dong, G.1    Chen, Z.2    Li, Z.Y.3    Yeh, N.T.4    Bancroft, C.C.5    Van Waes, C.6
  • 22
    • 0023661693 scopus 로고
    • Scatter factor is a fibroblast-derived modulator of epithelial cell mobility
    • Stoker M, Gherardi E, Perryman M and Gray J: Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature 327: 239-242, 1987.
    • (1987) Nature , vol.327 , pp. 239-242
    • Stoker, M.1    Gherardi, E.2    Perryman, M.3    Gray, J.4
  • 23
    • 11144358083 scopus 로고    scopus 로고
    • Reduced HGF expression in subcutaneous CT26 tumor genetically modified to secrete NK4 and its possible relation with antitumor effects
    • Kubota T, Fujiwara H, Amaike H, et al: Reduced HGF expression in subcutaneous CT26 tumor genetically modified to secrete NK4 and its possible relation with antitumor effects. Cancer Sci 95: 321-327, 2004.
    • (2004) Cancer Sci , vol.95 , pp. 321-327
    • Kubota, T.1    Fujiwara, H.2    Amaike, H.3
  • 24
    • 0034547912 scopus 로고    scopus 로고
    • HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice
    • Kuba K, Matsumoto K, Date K, Shimura H, Tanaka M and Nakamura T: HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice. Cancer Res 60: 6737-6743, 2000.
    • (2000) Cancer Res , vol.60 , pp. 6737-6743
    • Kuba, K.1    Matsumoto, K.2    Date, K.3    Shimura, H.4    Tanaka, M.5    Nakamura, T.6
  • 25
    • 0031583998 scopus 로고    scopus 로고
    • HGF/NK4 is a specific antagonist for pleiotrophic actions of hepatocyte growth factor
    • Date K, Matsumoto K, Shimura H, Tanaka M and Nakamura T: HGF/NK4 is a specific antagonist for pleiotrophic actions of hepatocyte growth factor. FEBS Lett 420: 1-6, 1997.
    • (1997) FEBS Lett , vol.420 , pp. 1-6
    • Date, K.1    Matsumoto, K.2    Shimura, H.3    Tanaka, M.4    Nakamura, T.5
  • 26
    • 77952812169 scopus 로고    scopus 로고
    • Committee of the National Cancer Research Institute: Guidelines for the welfare and use of animals in cancer research
    • Workman P, Aboagye EO, Balkwill F, et al: Committee of the National Cancer Research Institute: Guidelines for the welfare and use of animals in cancer research. Br J Cancer 102: 1555 1577, 2010.
    • (2010) Br J Cancer , vol.102 , pp. 1555-1577
    • Workman, P.1    Aboagye, E.O.2    Balkwill, F.3
  • 27
    • 0034693753 scopus 로고    scopus 로고
    • Met receptor tyrosine kinase: Enhanced signaling through adapter proteins
    • Furge KA, Zhang YW and Vande Woude GF: Met receptor tyrosine kinase: enhanced signaling through adapter proteins. Oncogene 19: 5582-5589, 2000.
    • (2000) Oncogene , vol.19 , pp. 5582-5589
    • Furge, K.A.1    Zhang, Y.W.2    Vande Woude, G.F.3
  • 28
    • 67349115229 scopus 로고    scopus 로고
    • NK4, an HGF antagonist, prevents hematogenous pulmonary metastasis by inhibiting adhesion of CT26 cells to endothelial cells
    • Kubota T, Taiyoh H, Matsumura A, et al: NK4, an HGF antagonist, prevents hematogenous pulmonary metastasis by inhibiting adhesion of CT26 cells to endothelial cells. Clin Exp Metastasis 26: 447-456, 2009.
    • (2009) Clin Exp Metastasis , vol.26 , pp. 447-456
    • Kubota, T.1    Taiyoh, H.2    Matsumura, A.3
  • 29
    • 0027482251 scopus 로고
    • Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract
    • Brown LF, Berse B, Jackman RW, et al: Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res 53: 4727-4735, 1993.
    • (1993) Cancer Res , vol.53 , pp. 4727-4735
    • Brown, L.F.1    Berse, B.2    Jackman, R.W.3
  • 30
    • 0035887435 scopus 로고    scopus 로고
    • Inhibition of growth, invasion, and metastasis of human pancreatic carcinoma cells by NK4 in an orthotopic mouse model
    • Tomioka D, Maehara N, Kuba K, et al: Inhibition of growth, invasion, and metastasis of human pancreatic carcinoma cells by NK4 in an orthotopic mouse model. Cancer Res 61: 7518-7524, 2001.
    • (2001) Cancer Res , vol.61 , pp. 7518-7524
    • Tomioka, D.1    Maehara, N.2    Kuba, K.3
  • 31
    • 0036796020 scopus 로고    scopus 로고
    • Tumor suppression through angiogenesis inhibition by SUIT-2 pancreatic cancer cells genetically engineered to secrete NK4
    • Saimura M, Nagai E, Mizumoto K, et al: Tumor suppression through angiogenesis inhibition by SUIT-2 pancreatic cancer cells genetically engineered to secrete NK4. Clin Cancer Res 8: 3243-3249, 2002.
    • (2002) Clin Cancer Res , vol.8 , pp. 3243-3249
    • Saimura, M.1    Nagai, E.2    Mizumoto, K.3
  • 32
    • 0032477844 scopus 로고    scopus 로고
    • Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: The case for paracrine amplification of angiogenesis
    • Van Belle E, Witzenbichler B, Chen D, et al: Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis. Circulation 97: 381-390, 1998.
    • (1998) Circulation , vol.97 , pp. 381-390
    • Van Belle, E.1    Witzenbichler, B.2    Chen, D.3
  • 33
    • 0035102323 scopus 로고    scopus 로고
    • Hepatocyte growth factor enhances vascular endothelial growth factor-induced angiogenesis in vitro and in vivo
    • Xin X, Yang S, Ingle G, et al: Hepatocyte growth factor enhances vascular endothelial growth factor-induced angiogenesis in vitro and in vivo. Am J Pathol 158: 1111-1120, 2001.
    • (2001) Am J Pathol , vol.158 , pp. 1111-1120
    • Xin, X.1    Yang, S.2    Ingle, G.3
  • 34
    • 70149095573 scopus 로고    scopus 로고
    • Cross-talk between the VEGF-A and HGF signalling pathways in endothelial cells
    • Sulpice E, Ding S, Muscatelli-Groux B, et al: Cross-talk between the VEGF-A and HGF signalling pathways in endothelial cells. Biol Cell 101: 525-539, 2009.
    • (2009) Biol Cell , vol.101 , pp. 525-539
    • Sulpice, E.1    Ding, S.2    Muscatelli-Groux, B.3
  • 35
    • 10644234769 scopus 로고    scopus 로고
    • The role of hypoxia-induced factors in tumor progression
    • Vaupel P: The role of hypoxia-induced factors in tumor progression. Oncologist 9 (Suppl 5): 10-17, 2004.
    • (2004) Oncologist , vol.9 , Issue.SUPPL. 5 , pp. 10-17
    • Vaupel, P.1
  • 36
    • 0037064010 scopus 로고    scopus 로고
    • Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells
    • Fukuda R, Hirota K, Fan F, Jung YD, Ellis LM and Semenza GL: Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells. J Biol Chem 277: 38205-38211, 2002.
    • (2002) J Biol Chem , vol.277 , pp. 38205-38211
    • Fukuda, R.1    Hirota, K.2    Fan, F.3    Jung, Y.D.4    Ellis, L.M.5    Semenza, G.L.6
  • 37
    • 0037293542 scopus 로고    scopus 로고
    • Phosphatidylinositol 3-kinase and mek1/2 are necessary for insulin-like growth factor-I-induced vascular endothelial growth factor synthesis in prostate epithelial cells: A role for hypoxia-inducible factor-1?
    • Burroughs KD, Oh J, Barrett JC and DiAugustine RP: Phosphatidylinositol 3-kinase and mek1/2 are necessary for insulin-like growth factor-I-induced vascular endothelial growth factor synthesis in prostate epithelial cells: a role for hypoxia-inducible factor-1? Mol Cancer Res 1: 312-322, 2003.
    • (2003) Mol Cancer Res , vol.1 , pp. 312-322
    • Burroughs, K.D.1    Oh, J.2    Barrett, J.C.3    Diaugustine, R.P.4
  • 38
    • 85047695527 scopus 로고    scopus 로고
    • Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis
    • Niu G, Wright KL, Huang M, et al: Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene 21: 2000-2008, 2002.
    • (2002) Oncogene , vol.21 , pp. 2000-2008
    • Niu, G.1    Wright, K.L.2    Huang, M.3
  • 39
    • 0037435011 scopus 로고    scopus 로고
    • Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway
    • Wei LH, Kuo ML, Chen CA, et al: Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway. Oncogene 22: 1517-1527, 2003.
    • (2003) Oncogene , vol.22 , pp. 1517-1527
    • Wei, L.H.1    Kuo, M.L.2    Chen, C.A.3
  • 40
    • 51649096739 scopus 로고    scopus 로고
    • Signal transducer and activator of transcription 3 is required for hypoxia-inducible factor-1alpha RNA expression in both tumor cells and tumor-associated myeloid cells
    • Niu G, Briggs J, Deng J, et al: Signal transducer and activator of transcription 3 is required for hypoxia-inducible factor-1alpha RNA expression in both tumor cells and tumor-associated myeloid cells. Mol Cancer Res 6: 1099-1105, 2008.
    • (2008) Mol Cancer Res , vol.6 , pp. 1099-1105
    • Niu, G.1    Briggs, J.2    Deng, J.3
  • 41
    • 57349168511 scopus 로고    scopus 로고
    • STAT3 inhibits the degradation of HIF-1alpha by pVHL-mediated ubiquitination
    • Jung JE, Kim HS, Lee CS, et al: STAT3 inhibits the degradation of HIF-1alpha by pVHL-mediated ubiquitination. Exp Mol Med 40: 479-485, 2008.
    • (2008) Exp Mol Med , vol.40 , pp. 479-485
    • Jung, J.E.1    Kim, H.S.2    Lee, C.S.3
  • 42
    • 24644457736 scopus 로고    scopus 로고
    • Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways
    • Xu Q, Briggs J, Park S, et al: Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways. Oncogene 24: 5552-5560, 2005.
    • (2005) Oncogene , vol.24 , pp. 5552-5560
    • Xu, Q.1    Briggs, J.2    Park, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.